In early 2006, researchers found a virus that could draw a link between prostate cancer and a particular genetic mutation. The discovery could open new avenues for research of the disease.

“Prostate cancer is a major health issue for men over 50,” said Dr. Dale McCord, President/CEO of Atlanta Oncology Associates (AOA), one of the largest radiation therapy practices in the Southeast. “Any advance in research for this disease would be a breakthrough.”

AOA has been treating and curing prostate cancer for more than thirty years. The practice is a recognized leader in the Atlanta metro region in prostate cancer technology and expertise.

The discovery of the virus, called XMRV, could prove to be groundbreaking, as it indicates that an infectious disease may cause this type of cancer. It proves the importance of continued clinical research in this and other types of cancer.

 “These findings are very important in terms of cancer research,” said Dr. Bruce Feinberg, President/CEO of Georgia Cancer Specialists (GCS), the largest oncology/hematology practice in the Southeast. “They could bring about changes in the prevention and treatment of prostate cancer.”